Indefinite Delivery Contract N6264523D5002
Award Date
12/2/22
Last Date to Order
8/31/23
Federal Agency
Bureau of Medicine and Surgery
Ultimate Awardee
Siemens Aktiengesellschaft
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of the Navy Bureau of Medicine and Surgery awarded Siemens Healthcare Diagnostics Inc. an indefinite delivery contract with a potential value of $249,985.26 for the delivery of LSD reagent kits. Under this contract, Siemens Healthcare Diagnostics Inc. received ten delivery orders from various Department of Defense agencies totaling $249,985.26 to supply LSD reagent kits for use in forensic toxicology drug testing laboratories. The reagent kits will support substance identification...
The Department of the Navy Bureau of Medicine and Surgery (BUMED) awarded an Indefinite Delivery Contract (IDC) valued at $825,606.25 to Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, to provide amphetamine (AMP) and methamphetamine (METH) reagent kits and associated laboratory diagnostic equipment and services. The contract was awarded on June 17, 2019 without any set-aside designations. Under the IDC, Siemens Healthcare Diagnostics has received multiple firm...
The federal contract IDV award N0018924DZ016 is a $4,125,000 single-award Indefinite Delivery Contract issued by the Naval Supply Systems Command, a defense agency, to Siemens Healthcare Diagnostics Inc. The contract has a period of performance through September 30, 2029 and is for the procurement of LSD reagent kits and related products to support the Defense Department's Directed Drug Reduction Program (DDRP). Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft,...
The Department of the Navy Bureau of Medicine and Surgery awarded Siemens Healthcare Diagnostics Inc. a single award indefinite delivery contract with a potential value of $4,504,500 to provide fentanyl reagent kits. Under this contract vehicle, Siemens Healthcare Diagnostics Division has received four firm fixed price delivery orders totaling $546,000 to supply ARK FENTANYL II products and services in support of the Bureau's medical research and healthcare programs. Performance is to take place...
Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, has been awarded multiple firm fixed price delivery orders by various U.S. federal agencies to provide 6-AM reagent kits and related laboratory diagnostic products and services. The Department of the Navy Bureau of Medicine and Surgery, Department of the Air Force Air Education and Training Command, Defense Health Agency, and Department of the Army Medical Command have all issued awards to Siemens Healthcare...
The U.S. Department of the Navy's Bureau of Medicine and Surgery has awarded a single-award, indefinite delivery contract (IDC) to Microgenics Corporation's Clinical Diagnostics Division for the procurement of MDMA/MDA reagent kits. The $1,154,822.40 contract has a performance period from March 2024 to March 2029. This IDC will provide the Department of Defense Drug Demand Reduction Program with a variety of immunoassay reagent test kits and related laboratory supplies to support substance abuse...
The Department of the Army Medical Command awarded Siemens Healthcare Diagnostics Inc., a division of Siemens Aktiengesellschaft, a single-award Blanket Purchase Agreement (BPA) valued at up to $6,743,294.25 to provide medical reagents, test kits, and consumables compatible with Siemens Dimension EXL 200 Integrated Chemistry and Immulite 2000 Immunoassay Systems. This IDV allows Army medical treatment facilities to efficiently order testing supplies and services from the prime contractor to...
The Department of Defense (DoD) has awarded Microgenics Corporation, a subsidiary of Thermo Electron Corporation, an indefinite delivery contract (IDC) worth up to $5,515,434.90 to provide benzodiazepine immunoassay reagent kits and related laboratory supplies in support of the DoD Drug Demand Reduction Program (DDRP). This single-award IDC has a period of performance through April 30, 2028 and does not utilize any set-aside designations. Under this IDC, Microgenics has received numerous...
The U.S. Navy Bureau of Medicine and Surgery (BUMED) awarded a single-award Indefinite Delivery Contract (IDC) to Siemens Healthcare Diagnostics Inc. valued at $100,560 to provide "COST PER REPORTABLE RESULT BLOOD GAS ANALYZER" services. This IDC enables BUMED's medical treatment facilities to efficiently order diagnostic equipment, reagents, consumables, and associated maintenance support services from Siemens to sustain critical laboratory operations. Under this IDC, Siemens has...
Siemens Healthcare Diagnostics Inc. was awarded a single award indefinite delivery contract by the Department of the Army Medical Command on October 1, 2016, with a potential value of $650,680.40. Under this contract, Siemens Healthcare Diagnostics delivers reagents for the MCART LAC 250 blood gas analyzer to support laboratory operations at various Army Medical Command facilities. Delivery orders issued against this contract from Fiscal Years 2018 through 2021 have provided these reagents...